Evidence map›Paper›PMID 36237432›Full record

ArticleFrontiers in cellular and infection microbiology2022

Refractory

Dongsheng Liu, Jinyun Wang, Yong Xie

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07704255 (Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07704255 phase4recruitingnot on this mapstarted 2026, after this paper: background citation

Study on the Effect of Fecal Microbiota Transplantation on Eradication of Refractory Helicobacter Pylori Infection

TypeinterventionalSponsorSichuan Provincial People's HospitalRan2026 to 2026Enrolled10ConditionsHelicobacter Pylori InfectionArmstransanal fecal bacteria transplant
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. OccultFrontiers in microbiology · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Effect ofFrontiers in oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dongsheng LiuDigestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Jinyun WangDigestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Yong XieDigestive Disease Hospital, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Nanchang University · CNFirst Affiliated Hospital of Nanchang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Curing refractory Methods: We designed a clinical retrospective study involving 32 subjects divided into three groups: 1. nAGHp.a, treatment-naïve patients with Results: There were significant differences between the Conclusion: Significant alterations occurred in the gastric microbiota when eradication of

Indexed as

Helicobacter InfectionsHelicobacter pyloriMicrobiotaBacterial Secretion SystemsGastric MucosaGlutathioneHumansLactobacillusLipopolysaccharidesRetrospective StudiesRNA, Ribosomal, 16SStomachSulfurTerpenesUbiquinoneVitaminsBacterial Secretion SystemsGlutathioneLipopolysaccharidesRNA, Ribosomal, 16SSulfurTerpenesUbiquinoneVitamins16S rRNA sequencingbacteria functional predictiongastric microbiotaH. pylori eradicationRefractory H. pylori infection

Identifiers

PMID36237432
PMCPMC9552320
OpenAlexW4297314425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.